Company Filing History:
1 out of 3 
1 out of 832,812 Years Active: 1993-1995
Title: **Zhi H Pei: Innovator in Antigenic Composition and Diagnostic Testing**
Introduction
Zhi H Pei, based in Nashville, TN, is a noteworthy inventor recognized for his contributions to the fields of microbiology and immunology. With two patents to his name, Pei has made significant strides in developing diagnostic tools and vaccines for detecting infections caused by Campylobacter jejuni and Campylobacter coli.
Latest Patents
Zhi H Pei's latest patents include an innovative antigenic composition aimed at inducing protective antibodies against Campylobacter infections. The first patent describes antisera against a PEB1 antigen from Campylobacter jejuni, which can be utilized as a vaccine. This composition plays a crucial role in detecting infections from both Campylobacter coli and Campylobacter jejuni. The second patent focuses on diagnostic detection kits that incorporate these novel antigenic compositions or specific antisera. These kits promise a significant advancement in testing for the presence of these pathogens, emphasizing the molecular weight and isoelectric properties of the PEB1 and PEB3 antigens.
Career Highlights
Throughout his career, Zhi H Pei has been associated with various prestigious organizations, including Enteric Research Laboratories Inc. His work has profoundly impacted the understanding and management of Campylobacter infections, leading to the development of effective diagnostic tests and potential vaccine solutions.
Collaborations
Pei has collaborated with notable scientists, including Martin J Blaser and Richard T Ellison III. These partnerships have fostered an environment of innovation and shared knowledge in the advancements of microbiological research.
Conclusion
Zhi H Pei’s contributions to antigenic compositions and diagnostic testing highlight the importance of innovation in combating infectious diseases. His work not only aids in the detection and understanding of Campylobacter infections but also paves the way for future advancements in vaccine development and public health.